Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Current Deferred Tax Assets (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Current Deferred Tax Assets for 4 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Tax Assets rose 10.16% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Dec 2025, up 10.16%, and an annual FY2025 reading of $1.1 billion, up 10.16% over the prior year.
  • Current Deferred Tax Assets was $1.1 billion for Q4 2025 at GE HealthCare Technologies, up from $417.0 million in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $1.1 billion in Q4 2025 and bottomed at $359.0 million in Q1 2025.
  • Average Current Deferred Tax Assets over 4 years is $765.7 million, with a median of $981.5 million recorded in 2022.
  • The sharpest move saw Current Deferred Tax Assets tumbled 65.22% in 2024, then grew 15.51% in 2025.
  • Year by year, Current Deferred Tax Assets stood at $989.0 million in 2022, then grew by 1.11% to $1.0 billion in 2023, then decreased by 2.6% to $974.0 million in 2024, then grew by 10.16% to $1.1 billion in 2025.
  • Business Quant data shows Current Deferred Tax Assets for GEHC at $1.1 billion in Q4 2025, $417.0 million in Q3 2025, and $1.1 billion in Q2 2025.